Intended for healthcare professionals

Letters Covid-19: Molnupiravir effects

Getting molnupiravir to patients in a timely way is likely to be problematic

BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2648 (Published 02 November 2021) Cite this as: BMJ 2021;375:n2648
  1. Peter M B English, public health physician
  1. Epsom, UK
  1. petermbenglish{at}gmail.com

I look forward to seeing more details about the effects of molnupiravir on covid-19, preferably in a peer reviewed publication.1

I have commented on this elsewhere.2

I was involved in trying to get people with flu-like symptoms antiviral chemoprophylaxis in the early days of the 2010 flu pandemic. Because ministers had said that everybody with such symptoms must be given chemoprophylaxis, we were not permitted to prioritise those at greatest …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription